HopeStage
Back to all studies
Active Not RecruitingNCT06433635

Sequential Multiple Assignment Randomized Trial for Depression in bipolarity

Medication studyAges 18–75United States + Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
Birmingham and 17 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 1, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
2,726
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States, Canada
Age range
From 18 Years to 75 Years
Official registry ID
NCT06433635
Official title
Show the full official title

Sequential Multiple Assignment Randomized Trial for Bipolar Depression

Recruitment & locations

Not recruiting

Birmingham, United States · Bloomington, United States · Baltimore, United States

14 more locations
  • Belmont, United States
  • Boston, United States
  • Ann Arbor, United States
  • Grand Rapids, United States
  • Albuquerque, United States
  • New York, United States
  • Chapel Hill, United States
  • Cleveland, United States
  • Philadelphia, United States
  • Pittsburgh, United States
  • Austin, United States
  • Dallas, United States
  • Houston, United States
  • Vancouver, Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Cariprazine, Aripiprazole/Escitalopram combination, Quetiapine and Lurasidone.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies